Detalles de la búsqueda
1.
Transplant benefit-based offering of deceased donor livers in the United Kingdom.
J Hepatol
; 2024 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38521169
2.
High prevalence of diabetes among young First Nations Peoples with metabolic dysfunction-associated steatotic liver disease: a population-based study in Australia.
Int J Equity Health
; 23(1): 84, 2024 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38689295
3.
Indications and outcomes of transjugular intrahepatic portosystemic shunt insertion in two regional Australian hepatology centres.
Intern Med J
; 2024 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38654627
4.
Diabetes mellitus and the progression of non-alcoholic fatty liver disease to decompensated cirrhosis: a retrospective cohort study.
Med J Aust
; 219(8): 358-365, 2023 Oct 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37749902
5.
Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists.
Ann Hepatol
; 28(6): 101142, 2023 Jul 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37468097
6.
A discrete choice experiment to elicit preferences for a liver screening programme in Queensland, Australia: a mixed methods study to select attributes and levels.
BMC Health Serv Res
; 23(1): 950, 2023 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37670274
7.
Retreatment for hepatitis C virus direct acting antiviral therapy virological failure in primary and tertiary settings: the REACH-C cohort.
J Viral Hepat
; 2022 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35583922
8.
Assessment of clinically significant portal hypertension by two-dimensional shear wave elastography.
Eur J Clin Invest
; 52(6): e13750, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35040495
9.
An exploration of barriers and facilitators to implementing a nonalcoholic fatty liver disease pathway for people with type 2 diabetes in primary care.
Diabet Med
; 39(6): e14799, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35100462
10.
The fate of indeterminate liver lesions: What proportion are precursors of hepatocellular carcinoma?
BMC Gastroenterol
; 22(1): 118, 2022 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35272611
11.
Validation of the New Diagnostic Criteria for Clinically Significant Portal Hypertension by Platelets and Elastography.
Dig Dis Sci
; 67(7): 3327-3332, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34739624
12.
Implementing the right care in the right place at the right time for non-alcoholic fatty liver disease (NAFLD-RRR study): a study protocol for a community care pathway for people with type 2 diabetes.
BMC Health Serv Res
; 22(1): 487, 2022 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35413987
13.
Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients With Difficult to Cure Characteristics.
Clin Infect Dis
; 73(9): e3288-e3295, 2021 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32887983
14.
Performance of simple serum-based tests to exclude cirrhosis prior to hepatitis C treatment in non-hospital settings in Australia.
Intern Med J
; 51(4): 533-539, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31994285
15.
Changing prevalence of aetiological factors and comorbidities among Australians hospitalised for cirrhosis.
Intern Med J
; 51(5): 691-698, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32096890
16.
Is methotrexate hepatotoxicity associated with cumulative dose? A systematic review and meta-analysis.
Australas J Dermatol
; 62(2): 130-140, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33769558
17.
Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD).
BMC Health Serv Res
; 20(1): 335, 2020 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32316984
18.
Letter to the Editor: The impact of a paracentesis education program among junior doctors.
Liver Transpl
; 30(1): E11, 2024 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37729525
19.
Cardiovascular morbidity and mortality is increased post-liver transplantation even in recipients with no pre-existing risk factors.
Liver Int
; 39(8): 1557-1565, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31233663
20.
Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease.
BMC Gastroenterol
; 19(1): 122, 2019 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31296161